Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01997905 · ClinicalTrials.gov registry record · Phase 1
Stroke Feasibility Study
A Phase 1 study of Atrial Fibrillation and Afib, sponsored by AtriCure.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
- 7
- Study locations
NCT01997905 is a Phase 1 study of Atrial Fibrillation and Afib that has completed, run by AtriCure. The registered enrollment target is 13 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (100% lower). The trial reports 7 study locations across 7 states.
The verdict
NCT01997905, a Phase 1 study of Atrial Fibrillation and Afib, has completed, sponsored by AtriCure.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a feasibility study to assess the safety and efficacy of the AtriCure AtriClip when placed via Minimally Invasive Surgical Deployment to the Left Atrial Appendage. The purpose is for evaluation of Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation who are unable to take Oral Anticoagulants.
Conditions Studied
Interventions
- DEVICE AtriClip LAA Exclusion Device
Study Locations (7)
California
- St. Helena Hospital - St. Helena
Florida
- Mercy Hospital - Miami
Indiana
- Franciscan St. Francis Health - Indianapolis
Ohio
- Good Samaritan Hospital - Cincinnati
Texas
- Houston Methodist Hospital - Houston
Virginia
- University of Virginia - Charlottesville
Wisconsin
- Aspirus - Wausau
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01997905
The ClinicalTrials.gov registry entry for NCT01997905 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (100% lower). The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which AtriClip LAA Exclusion Device is the first listed.
NCT01997905 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Indiana.
Frequently Asked Questions
What is clinical trial NCT01997905 about?
NCT01997905 is a clinical study titled "Stroke Feasibility Study". This is a feasibility study to assess the safety and efficacy of the AtriCure AtriClip when placed via Minimally Invasive Surgical Deployment to the Left Atrial Appendage. The purpose is for evaluation of Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation who are unable to take Oral...
What is the current status of trial NCT01997905?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2014-01. Estimated completion is 2015-08.
What conditions does trial NCT01997905 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Afib.
What interventions are being tested in trial NCT01997905?
The interventions under investigation include: AtriClip LAA Exclusion Device (DEVICE).
Who is sponsoring clinical trial NCT01997905?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01997905 being conducted?
This trial has 7 study locations across California, Florida, Indiana, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING · Phase 1
-
Synaptic Plasticity in the Epicardial Ganglionated Plexi
RECRUITING · Phase 1
-
Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study
COMPLETED · Phase 1
-
Effect of Diltiazem on Pharmacokinetics of BMS-914392
COMPLETED · Phase 1
-
Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac Surgery
COMPLETED · Phase 1
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.